MALVERN, PA — Ocugen, Inc. (Nasdaq: OCGN) announced it has completed enrollment for the Phase 3 liMeliGhT clinical trial evaluating OCU400, a gene therapy candidate for retinitis pigmentosa, a group ...
India has become a global hub for Global Capability Centres (GCCs) and AI-led innovation, driving high demand for specialized ...
The Chosun Ilbo on MSN
Study: Daily multivitamins slow biological aging
A study has found that taking daily multivitamins may slow the aging process. The research team from Brigham and Women’s Hospital, Harvard Medical School, published their analysis comparing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results